Dr. Pierre B. Fayad, MD

Dr. Fayad practices at Nebraska Medical Center in Omaha, Nebraska, part of University of Nebraska System.

Dr. Fayad's NPI, 1730137084, was assigned on May 5, 2006. Dr. Fayad graduated from Sapienza University of Rome in 1983. Dr. Fayad holds Nebraska license 21884.

Dr. Fayad's primary practice is Nebraska Medical Center, at 988102 Nebrasks Medical Center, Omaha, NE 68198 in Douglas County. The practice phone is (402) 559-4000. Dr. Fayad also practices at Nebraska Medical Center, 987400 Nebraska Medical Ctr, Omaha, NE 68198.

Dr. Fayad's primary practice is Nebraska Medical Center in Omaha, Nebraska, part of University of Nebraska System. Dr. Fayad is also affiliated with Bellevue Medical Center. The medical group on file is UNMC Physicians. Dmand AI also links Dr. Fayad to 1 more hospital, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Fayad practices, 3 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Fayad's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Fayad is board certified in neurology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Fayad's licenses on file in 4 states: Nebraska, Iowa, Connecticut and New York.

Dmand AI lists acute mini-stroke (TIA), cerebrovascular disease, mini-stroke (TIA), seizures and stroke among the conditions Dr. Fayad treats.

CMS data shows 475 Medicare services from Dr. Fayad across 7 procedure codes in 2024, for 263 Medicare patients. Medicare paid $34,238 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 263 Medicare patients who saw Dr. Fayad in 2024. The largest group is 65 to 74, with 106 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 11% are also on Medicaid. Their average risk score is 1.74, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Fayad's median patient age at 74, with 51% women.

In 2024, Dr. Fayad wrote 37 Medicare Part D claims. 97% of them were for generic drugs. CMS names the drug for 31 of them, across 2 drugs with 11 or more claims each, at $4,192 in total drug cost. In 2021, CMS named 21 claims across 1 drug.

Dr. Fayad accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 46 papers to Dr. Fayad, published from 2003 to 2022. 2011 was the busiest year, with 2. The most frequent topics are Stroke, Cerebrovascular Disorders and Ischemic Attack, Transient. Dr. Fayad has published most often in Stroke. Dr. Fayad's most frequent co-authors are John Christopher Chaloupka, MD, John C. Brust, MD and Larry Bruce Goldstein, MD.

Dmand AI links Dr. Fayad to 1 clinical trial. Conditions studied include Ischemic Stroke and Stroke.

CMS Open Payments shows 26 general payments to Dr. Fayad from 4 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 79% of the total. Janssen Research & Development, LLC paid the most, $20,166. It also lists 35 research payments totaling $33,880 from 2016 to 2023.

Dmand AI lists 1 award for Dr. Fayad, most recently CMS Stage 1 EHR in 2013.

Dr. Fayad graduated from Sapienza University of Rome in 1983.

Dr. Fayad is in network with 16 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.